Day 1 :
Keynote Forum
Faruque Ghanchi
Bradford Teaching Hospitals NHS Foundation Trust
UK
Keynote: Diabetic retina: Macula and beyond
Time : 09:10-09:35
Biography:
Faruque Ghanchi is a Consultant Ophthalmologist at the Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK since 1999. He has been a Senior Consultant and leading medical Retina Specialist reputed for his work in the UK and abroad. He pioneered the medical retina service at Bradford, establishing the first centre to provide PDT for macular degeneration in Yorkshire. He has served on the Rt. Honorable Secretary of State’s advisory panel for vision standards for driving (DVLA), worked as Expert on the National Institute of Clinical Excellence (NICE) appraisal committees, the examination committee and the scientific committee of the Royal College of Ophthalmologists. He has worked as an Associate Sub-Dean for Admissions for the University of Leeds Medical School. He has Co-Founded the Yorkshire Retina Society which has been promoting education and research in retinal disorders over a decade. He has been Examiner for the FRCOphth and FRCS (Glasgow) exams. He is the Vice Chair of the National Institute of Health Research (NIHR) Ophthalmology Clinical Research Network (CRN) and is the National Lead for Industry studies for the NIHR CRN Ophthalmology. He has many publications in peer reviewed journals to his name.
Abstract:
Diabetic retinopathy is a leading cause of blindness globally. The prevalence of diabetes is staggering with increasing incidence of the disease worldwide, diabetic retinopathy will be a public health challenge. This talk would provide an update on diabetic retinopathy screening based on the UK experience. The principles of systematic screening program to identify potential sight threatening disease will be discussed. The talk would also provide information on monitoring clinics for diabetic retinopathy. The clinical practice for diabetic maculopathy and the management of diabetic macular edema (DMO) will be discussed based on current research evidence. The talk will include discussion on various pharmacological agents and relevance of laser treatment in management of DMO. The management for diabetic retinopathy will be covered especially when co-existent with diabetic macular edema. Delegates will benefit from global view and update on clinical management of patients with diabetic retinopathy.
Keynote Forum
Naj Sharif
Santen Inc.,
USA
Keynote: Glaucoma treatment: Novel drugs and devices on the horizon
Time : 09:35-10:00
Biography:
Naj Sharif is a graduate of Southampton University, England (UK), where he received his BSc in Biochemistry and Physiology and his PhD in Neuroscience. He has been in the pharmaceutical industry for 31-years holding leadership positions of increasing scope and responsibility, spanning discovery research, drug development and regulatory affairs. His 22-year R&D tenure at Alcon resulted in his contributions to the discovery/development and US FDA and EMA approvals of Travatan® (Travoprost), Simbrinza®, Patanol® (Olopatadine) and Emedine® (Emedastine), to treat glaucoma/ocular hypertension and ocular allergies. He has also discovered, patented and out-licensed the first FP-prostaglandin-receptor antagonist (AL-8810) that is proving a useful pharmacological tool to dissect the role of FP-receptors in human and animal diseases. He is an Associate Editor of J. Ocular Pharmacology & Therapeutics, and an Editorial Board Member of Molecular Vision, Current Eye Research and European Journal of Pharmacology. He is an Adjunct Professor at several universities and a Thesis Advisor for MS- and PhD graduate students. He has published >190 scientific articles and edited 2 Neuroscience books. He is the Inventor of 22 issued US and EU patents (+ 20 pending patent applications) on ocular cell-lines and small novel molecules to treat human diseases of the CNS and the eye.
Abstract:
Glaucoma is a blinding disease encompassing a multitude of retinal/optic neuropathies. Primary open angle glaucoma (POAG) is the most prevalent form that afflicts > 70 million people world-wide and is projected to increase as better diagnosis is accomplished. Currently there is no cure for POAG, and only the common symptom of elevated intraocular pressure (IOP) can be treated. However, there are patients whose IOPs are considered “normal” or low enough, whose vision continues to deteriorate, and their glaucoma remains uncontrolled. These patients may need alternative interventions such as neuroprotective agents that can retard their loss of vision. While FP-prostaglandin agonists (FPGAs) are first-line therapy for reducing IOP and preventing retinal ganglion cell demise, most FPGAs are losing their patent protection and there are many patients who are refractory to FPGAs-treatment and/or are highly sensitive to the drug or its preservative formulations. Additionally, there is the issue of non-compliance of patients due to infirmity, forgetfulness, inaccuracy of delivery to the ocular surface and/or simple abstinence of treatment in view of the ocular side-effects like hyperemia, ocular irritation and/or ocular allergies caused by the drug(s). Furthermore, many patients with POAG and ocular hypertension (OHT) require more than one type of drug to reduce and control their IOPs. Therefore, numerous companies and academic institutions have been heavily engaged in research & development of new drugs and devices to lower IOP and maintain it to a normal level for long periods of time. This presentation will discuss some of the novel IOP-lowering drugs (e.g. Omidenepag Isopropyl [DE-117]; Rhopressa [AR-11324; Netarsudil]; Trabodenoson [INO-8875]; Latanoprostene Bunod [Latanoprost-nitric oxide donor conjugate]; CF101; sustained release devices/implants for PG agonist), combination products (e.g. Roclatan [Latanoprost+AR-11324 fixed-dose combination]) and innovative devices coupled with surgical procedures (e.g., iStent; Xen shunt; InnFocus MicroShunt) that could become mainstay treatment modalities for treating glaucomatous retinopathies in the near future.
- Retina & Retinal Disorders | Cornea & External Eye Disease | Ophthalmology Surgery
Location: Dubai
Chair
Christiane I. Falkner-Radler
Rudolf Foundation Hospital, Austria
Co-Chair
Stefan Mennel
Austria
Session Introduction
Stefan Mennel
LKH Feldkirch, Austria
Title: Binocular occlusion prior to retinal detachment surgery: A tomographic analysis by OCT
Biography:
Stefan Mennel has obtained his Medical degree from the University of Innsbruck, Austria. He has completed his Residency at the LKH Feldkirch in Austria. After two years of Medical Specialist in Feldkirch (Austria), he worked as an Assistant Medical Director at the Philipps University of Marburg, Germany from 2002. In 2008, he became a Professor of Ophthalmology. After working as an interim Director Medical Deputy Head at the University Marburg in 2009 and 2010, he was appointed as the Director of the Department LKH Feldkirch, University Teaching Hospital of the Medical University Innsbruck and Vienna. He assists as a Reviewer in more than 20 peer-reviewed journals and has been serving as an Editorial Board Member of repute. His main research interest is on imaging vitreoretinal structures and experimental research on the blood retinal barrier. His surgical experience comprises vitreoretinal surgery, anterior segment surgery including cataract surgery, glaucoma surgery and corneal transplantation.
Abstract:
Introduction: In previous years binocular occlusion was a routine treatment for acute vitreous hemorrhage and rhegmatogenous retinal detachment (RRD) prior to surgery. In most cases the acute hemorrhage settles enough for successful treatment of the originating pathology. In RRD binocular occlusion diminish sub-retinal fluid to improve preoperative diagnostic and treatment and can prevent a progression of the detachment. The reduction of sub-retinal fluid is still documented by fundus photography and fundus drawings. In this study, we introduced optical coherence tomography (OCT) for this purpose. OCT enables measurement of sub-retinal fluid and to compare similar areas after binocular occlusion.
Methods: 30 patients with RRD that were scheduled for treatment at the following day received OCT at the time of examination and at the following day prior to surgery.
Results: In 18 eyes the macula was attached at the first visit and in none of the cases a macular involvement was determined by OCT at the following day prior to surgery. In 12 cases the macula was already detached. In 11 eyes the retinal elevation decreased and in one case an increase was evident.
Conclusion: This fist study by using OCT to measure sub-retinal fluid and macular involvement in RRD demonstrated binocular occlusion as an effective treatment option to schedule retinal detachment surgery for the following day without the risk of macular involvement in RRD.
Biography:
Talal Althomali is an Associate Professor of Ophthalmology and the Vice Dean of Hospital Affairs at Taif University and a Consultant Physician of Pediatric Ophthalmology at King Khaled Eye Specialist Hospital, Riyadh and King Abdul-Aziz Specialist Hospital, Tertiary and Referral Center in the Western Region, Saudi Arabia. With outstanding educational and research activities, he has excellent experience in surgeries. He is active member of numerous ophthalmology organizations. Actively participated in many ophthalmology meetings including American academy meeting 2014, American Society of Cataract and Refractive Surgeons 2014, European Society of Cataract and Refractive Surgeon 2008-2015, World Congress of Pediatric Ophthalmology and Strabismus 2012 & 2015 and International Ophthalmology Congress 2014, where some of his research was selected to be amongst the top studies.
Abstract:
Introduction: Excimer laser surgeries correct refractive error by corneal tissue ablation, which also lead to the weakening of the biomechanical strength of the cornea and therefore, increase the risk of developing postoperative keratectasia. The incidence of post-refractive surgery ectasia is greatly enhanced by the presence of conditions associated with low residual stromal bed thickness (< 250 µm) either from excessive ablation (high myopia) or thick flap creation, or presence of pre-existing topographic abnormalities such as sub-clinical keratoconus. As the risk of post-refractive surgery ectatic complications, sub-clinical keratoconus is considered as a contraindication to LASIK. There are reports which suggest that patients with preoperative riskf actors could be offered PRK as an alternative to LASIK; however, the risk of progression to keratoconus after PRK still prevails. As such, general consensus has been that excimer laser ablation procedures should be avoided in eyes with sub-clinical keratoconus. In recent years, riboflavin-ultraviolet A (UVA) corneal collagen cross-linking (CXL) has been successfully used to halt the progression of keratoconus. CXL alone has helped in retarding or eliminating the progression of keratoconus and post-refractive surgery ectasia. Additionally, in highly irregular corneas with progressive keratoconus, the combination of topography-guided PRK with CXL has also been found to significantly decrease corneal irregularity and improve visual acuity as well as halt the progression of keratoconus at the same time. The combination of LASIK and accelerated CXL has also been evaluated for reducing the risk for postoperative keratectasia in a population at risk but with no corneal abnormalities and has been found to be safe and effective with respect to refractive outcomes. It has been established that prophylactic collagen cross-linking is safe in routine LASIK cases. Due to the successful use of CXL alone or in combination with topography guided PRK in eyes with manifest keratoconus, there has been a revival of interest about the possibility of performing laser vision correction safely in eyes with sub-clinical keratoconus. In patients with subclinical keratoconus, simultaneous CXL with PRK may offer both spectacle/contact lens freedom and stability of their ectatic disorder at the same time. This paper presents a series of patients with subclinical keratoconus, who have undergone combined, same-day, topography-guided PRK followed by accelerated CXL.
Aim: The purpose of the study was to evaluate the efficacy, safety and stability of visual and refractive outcomes of the combined topography guided PRK with accelerated CXL in eyes with subclinical keratoconus.
Methods: Simultaneous topography-guided PRK with accelerated CXL was performed in 140 eyes of 75 patients (mean age 25.73±5.2 years) with subclinical keratoconus and were followed up at 1, 3, 6 and 12 months. Study parameters included preoperative and postoperative uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction and keratometry (flat and steep).
Results: All refractive and keratometric parameters demonstrated a statistically significant improvement from baseline to postoperative 12 months. UDVA of 20/20 or better was achieved in 90.7% (127/140) eyes and 20/40 or better was achieved in 96.4% (135/140) eyes at last follow-up. Regarding refractive outcomes; 94.3% (132/140) eyes were within ±1.00 D of attempted refractive correction and 82.9% (116/140) eyes had an astigmatism of ≤ 0.25 D postoperatively as compared to 22.9% (32/140) eyes at preoperative levels. Regarding safety, 90.7% (127/140) eyes maintained their preoperative CDVA; 2.1% (3/140) eyes lost 1 line, 3.6% (5/140) eyes lost 2 lines and 3.6% (5/140) eyes lost 3 or more lines of CDVA. Corneal haze was observed in 7.14% (10/140) and corneal ectasia developed in 1 eye (0.7%).
Conclusion: Combining topography-guided PRK with accelerated CXL appears to be safe and effective surgical refractive procedure to offer spectacle-independence in eyes with subclinical keratoconus.
Kristina Mikek
Morela Okulisti
Slovenia
Title: Femtosecond laser or mikrokeratome: What to choose in LASIK?
Biography:
Kristina Mikek has completed her undergraduate education from University of Ljubljana, Medical Faculty, Slovenia. She did Residency in Ophthalmology at University Medical Center Ljubljana, Slovenia (1999-2003), Fellowship in Cataract and Refractive Surgery at Moorfields Eye Hospital, London, UK (2001), Fellowship in Cataract Surgery at University Eye Clinic Antwerp, Belgium (2002), Postgraduate Research, Magister of Science, University of Ljubljana, Slovenia (2002) and Fellowship Laser Refractive Surgery, University Eye Hospital Heraklion, Greece (2003). She has worked as a Consultant Ophthalmologist, Cornea and Cataract Surgery Specialist at University Eye Clinic, Ljubljana, Slovenia from 2003-2006 and she has been working as a Medical Director at Morela Okulisti, Center for Eye Surgery, Ljubljana, Slovenia since 2007.
Abstract:
Purpose: LASIK (laser in situ keratomileusis) is the far most preferred technique in laser refractive surgery with excimer laser. We use femtosecond laser technology for the creation of the flap.
Methods: When we decide for LASIK surgery we have to choose the right patient in terms of the parameters measured at the time of preoperative examinations: the amount of refraction with or without astigmatism and corneal thickness. Besides this, corneal topography and corneal back surface scanned with the Pentacam device are very important. For successful surgery we have to have the right value of the keratometric numbers and the right diameter of the cornea (WTW: White to White). Last but not the least in the decision for LASIK surgery with microkeratome or femtosecond laser in creation of the flap, is the anatomy of the orbit and the eyelids (deep set eyes).
Results: In the presentation, I will present in which patients we can use femtosecond LASIK refractive surgery, where LASIK surgery with the microkeratome is not possible or associated potential complications even in the hands of very experienced refractive surgeons.
Conclusion: Femto LASIK with femtosecond laser technology is far the most sophisticated and successful laser refractive surgery method even in patients, where LASIK surgery with microkeratome is not possible or could be associated with flap related complications during the surgery.
Felipe A Soria
Vissum Corporación Alicante
Spain
Title: MICS with toric intraocular lenses in keratoconus: Outcomes and predictability analysis of postoperative refraction
Biography:
Felipe Soria studied Medicine in the Adventist University in Argentina and did his specialty in Ophthalmology in the Vision Institute of Montemorelos University in Mexico. He made the subspecialties of Cornea, Refractive and Cataract surgery in Vissum Corporation with Dr. Jorge Alio for a period of two years. He has written more than 30 scientific articles and book chapters, and is the Editor of the book Femtosecond Laser Assisted Keratoplasty. He has participated with 40 communications in different international congress across the world. He owns the patent: Use of Mesothelial cells in Tissue Bioengineering and Artificial Tissues.
Abstract:
Aim: To investigate the visual and refractive outcomes, safety, efficacy and stability of cataract surgery in eyes with stable keratoconus.
Methods: 17 eyes (10 patients) diagnosed as stable keratoconus, aged from 34 to 73 years (56.63±12.47), underwent micro-incision cataract surgery (MICS) followed by implantation of toric intraocular lens (IOL). Seven of them were operated bilaterally and three unilaterally. A complete ophthalmological examinationwas performed preoperatively and postoperatively. The main outcome measures were: uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), keratometry and manifest refraction.
Results: Sphere changed from −1.77±6.57D (−11.00 to 7.00) preoperatively to 0.08±0.79D (−1.25 to 1.75) postoperatively (p=0.211), and cylinder changed from −2.95±1.71D (−7.00 to −0.75) to −1.40±1.13D (−3.25 to 0.00) ( p=0.016). UDVA (logMAR) changed from 1.33±0.95 (0.40 to 2.77) to 0.32±0.38 (0.00 to 1.30) (p=0.008) and CDVA (logMAR) changed from 0.32±0.45 (0.01 to 1.77) to 0.20±0.36 (−0.03 to 1.30) (p=0.013). Efficacy and safety indexes were 1.38±0.58 and 1.17±0.66, respectively. Refraction and corneal topography were stable during the follow-up (9.10±5.54 months, 3–15).
Conclusions: MICS surgery using corneal topography data and standard formulas for the calculation of the IOL power is a safe and effective procedure regarding keratometric stability, visual and refractive results.
Radwan Almousa
Chelsea and Westminster Hospital
UK
Title: Mohs micorographic surgery vs. wide excision and late reconstruction for periocular basal cell carcinoma treatment
Biography:
Radwan Almousa has completed his Basic Ophthalmology training from Royal Cornwall Hospital. He has completed 1 year Oculoplastic Fellowship from the National University Health System in Singapore, then another year of Cornea Fellowship from Queen Victoria Hospital in the UK. He is an Ophthalmology Consultant at Chelsea and Westminster Hospital in London. He has published 16 papers in reputed peer reviewed journals and continues to serve as a Reviewer for few ophthalmic journals.
Abstract:
Purpose: To analyze the outcome of basal cell carcinoma (BCC) treatment in a tertiary referral center in the UK.
Methods: Retrospective, comparative, interventional study of patients who underwent surgical treatment of periocular BCC between 2013 and 2015. Patients were divided into two groups; the first group had the BCC removed using Mohs microscopic surgery (MMS), the second group underwent wide excision with later reconstruction. The primary outcome was the recurrence rate in both group, the secondary outcomes were reconstructive technique, lesion site and size, histopathology, and rate of complications.
Results: One hundred forty-six patients (93 female, 53 male) with a total of 151 cases were treated. Median follow-up was 14 (range 6-40) months; median age was 74.4 (range 40.5-99.5) years. The BCC involved mostly the lower lid in 70 cases (46.3%), followed by medial canthus, upper lid, lower lid, brow, and lateral canthus, in 45 (29.8%), 14 (9.2%), 12 (7.9%) and 9 (5.9%) cases respectively. 102 patients had MMS surgery and 49 patients had wide excision. Most of the surgical defects were closed using local flaps (117) and the rest of the cases were closed using direct closure technique (26) and skin graft (8). In the MMS group, the average surgical defect (263.1±344.6 mm), was 3.75 times the original clinical tumor size (70.8±105.8 mm) (P<0.001). Three patients in the wide excision group had a recurrence of the BCC tumor. There was no recurrence in MMS group.
Conclusion: The microscopic BBC tumor is significantly larger than its clinical appearance. MMS is more effective in complete removal of the tumor than wide excision technique with less recurrence rate.
Christiane I Falkner-Radler
Rudolf Foundation Hospital
Austria
Title: 27-gauge vitrectomy for vitreoretinal disorders
Biography:
Christiane I Falkner-Radler is a full time attending Retinal Specialist and Surgeon at the Department of Ophthalmology, Rudolf Foundation Clinic, Vienna since 2008. She has conducted several clinical trials and has published several articles in peer-reviewed journals. Her areas of research interest are vitreoretinal disorders and surgical approaches, including retinal detachment surgery and macular surgery and on new advances in combined cataract and vitreoretinal surgery as well as intraoperative optical coherence tomography. She has presented free papers and posters at several international and national meetings and has been accepted as member in the Retina Society, the ASRS, the Club Jules Gonin, the Euretina, the AAO and the ARVO. In addition, she has completed the SOE-Leadership development program “EuLDP” 2010-2011. She has completed several Observerships with the Department of Ophthalmology at Weill Cornell Medical College, New York.
Abstract:
Purpose: To evaluate anatomic, functional and refractive outcomes after 27-gauge vitrectomy in a prospective study.
Methods: The study was designed to include patients presenting with vitreoretinal disorders (epiretinal membrane [ERM], macular holes, asteroid hyalosis and vitreomacular traction [VMT]) with or without coexisting significant cataract. Exclusion criteria were (1) patients with rhegmatogenous or tractional detachment, (2) previous vitreoretinal surgery and (3) the need for silicone oil tamponade. Surgical conditions using a scaled questionnaire, complication rates, IOP, functional and refractive outcomes were evaluated.
Results: Up to now, 60 patients, 41 females and 19 males with a mean age of 72 years, have completed the 3 months follow-up. The vitreoretinal diagnosis was ERM in 36 eyes, macular holes in 9 eyes, VMT in 2 eyes, and asteroid hyalosis in 13 eyes. 47 eyes cataract surgery was combined with vitrectomy. Intraoperative conditions were graded good to excellent. However, a slightly increased time needed for core vitrectomy was noted and particularly in hyperopic and left eyes the 27 gauge instruments were graded to be more flexible. No wound leakage was found and the IOP was stable in all eyes. Complication rates included a mild postoperative vitreous hemorrhage in one patient which spontaneously resolved during follow-up. Visual acuity improved in all patients and the refractive results in the combined cases were excellent.
Conclusions: These results suggest that 27 gauge vitrectomy with or without combined cataract surgery results in excellent wound architecture and offers promising functional and refractive results.
Sameen Afzal Junejo
Liaquat University of Medical and Health Sciences
Pakistan
Title: Role of oral Rifampcin in central serous chorioretinopathy (CSCR): Study of 31 cases
Biography:
Sameen Afzal Junejo Taken up fellowship FCPS from College of Physicians and Surgeons Pakistan in 1999. Published 27 papers in reputed journals. Interested in anterior segment and adenexia. Introduced new techniques in Phacoemulsification cataract surgery. At present working as Professor Institute of ophthalmology LUMHS-JAMSHORO, Pakistan.
Abstract:
Central serous chorioretinopathy (CSCR) is characterized by accumulation of fluid in between sensory retina and retinal pigment epithelium. Chronic CSCR present with frequent exacerbations and a poor visual prognosis. Various therapeutic measures are available for recent onset and recurrent/chronic CSR. Thus, novel therapies to combat this frustrating disorder are needed. We will present fifteen cases with recent and chronic CSCR treated with oral Rifampcin that completely resolved with 1 month of oral rifampcin therapy. As a cytochrome P450, 3A4 inducer, rifampin is thought to favorably alter the metabolism of endogenous steroids, thereby leading to an improvement in CSCR manifestations. The study of 31 cases of CSCR treated with half adult dose oral Rifampcin will be presented.
Biography:
Irina Mocanu, Romanian Ophthalmogist, graduated from the Bucharest Emergencies Eye Hospital. She has done a fellowship in University of Crete - Institute of Vision and Optics Heraklion, with Prof. Pallikaris. Also she did a fellowship in Advanced Microincision Phacoemulisification in Instituto de la Vision, University of Montemorelos - Mexico, having Dr. Felipe A. Soria as a tutor. Currently, she is doing a research on the effects of intraocular foreign bodies with forensic implications. She works in her own private practice dedicated mainly to anterior segment cases.
Abstract:
Purpose of review: This review outlines the advantages and the differences of femtosecond laser-assisted cataract surgery. (FLACS) following a coaxial or microincision cataract surgery phacoemulsification in the surgical outcomeand greater control of cataract surgery.
Recent findings: FLACS offers minimal tissue damage and extreme precision during corneal incision creation, continuous circular capsulorhexis (CCC) and nuclear fragmentation. It also allows diminishing the mean average ultrasound power to emulsify the nucleus followed by a coaxial or a biaxial procedure. The impact of reduced phacoemulsification energy on the corneal endothelium is an interesting topic that is being investigated. Despite its benefits, this technology has relevant financial issues and a high learning curve.
Summary: FemtoMICS appears to be surgically and statistically more efficient than the Femt-coaxial technique and Femtoincisions prove to be stable and do not change the corneal high order aberration significantly with favourable results of the triplanar configuration.
Mustafa Kamal Junejo
Isra Postgraduate Institute of Ophthalmology
Pakistan
Title: Central corneal thickness and crystalline lens changes after trabeculectomy
Biography:
Mustafa Kamal Junejo has completed his training at the age of 30 years from Aga Khan University Hospital Karachi Pakistan. He did his Membership exam from Royal College of Surgeons of Edinburgh United Kingdom. He is working as Senior Instructor/ Clinical & Academic Coordinator and In charge Cornea & External Eye Diseases Section. He has published more than 10 papers in reputed journals nationally and internationally. His areas of interests are Cornea, External Eye Disease and Refractive surgery, Medical Retina and Glaucoma.
Abstract:
Objectives: To determine changes in central corneal thickness (CCT) and crystalline lens status after Trabeculectomy in Glaucoma patients.
Materials & Methods: We retrospectively reviewed the records of 113 glaucoma patients who underwent trabeculectomy for the assessment of changes in central corneal thickness and crystalline lens status, from January 2013 to December 2014 at Section of Ophthalmology, Aga Khan University Hospital, Karachi. Patients’ characteristics, including demographics presentation, clinical factors and management were assessed from the medical records. Categorical variables were described in terms of frequencies and percentages and continuous variables were described in terms of mean and standard deviation. Data was analyzed using SPSS 19.0
Results: Mean age of patient was 53.3± 12.3 years. Before trabeculectomy, the mean CCT was 524.25 ±38.53 µm. After 12 months of surgery the mean CCT was 521.95±38.25 µm with correlation of 0.855 which was not statistically significant. The crystalline lens status assessment was reviewed in 108 patients because 5 patients were pseudophakic. Out of which 9 patients’ (8.3%) crystalline lens status was changed post 12 months of trabeculectomy keeping the LOCS III grading system as reference.
Conclusion: Central corneal thickness is assessed for accurate measurement of intraocular pressure to properly manage patients of glaucoma. In our study we concluded that there is no clinically significant change in central corneal thickness after drainage surgery so, it is not necessary to measure central corneal thickness after drainage surgery for accurate measurement of intraocular pressure. Crystalline lens status change was noticed in our study in particular to nuclear sclerotic lens changes increasing after trabeculectomy.
Sameen Afzal Junejo
Liaquat University of Medical and Health Sciences
Pakistan
Title: Phacoemulsification, phaco/MICS and ECCE through temporal approach in hard cataracts
Biography:
Sameen Afzal Junejo taken up fellowship FCPS from College of Physicians and Surgeons Pakistan in 1999. Published 27 papers in reputed journals. Interested in anterior segment and adenexia. Introduced new techniques in Phacoemulsification cataract surgery. At present working as Professor Institute of ophthalmology LUMHS-JAMSHORO, Pakistan.
Abstract:
Hard cataract extraction off and on creates problem for a phaco-surgeon and many times during surgery on table the procedure has to be shifted from small incision phaco-emulsification to large incision extra capsular cataract extraction. In this video presentation we will discuss how to perform all small incision cataract extraction techniques safely and comfortably in grade-III hard cataracts.